首页> Human vaccines & immunotherapeutics> Public health impact and cost-effectiveness of implementing gender-neutral immunization with the nonavalent human papillomavirus vaccine in South Korea.

Public health impact and cost-effectiveness of implementing gender-neutral immunization with the nonavalent human papillomavirus vaccine in South Korea.

导出 OA

翻译打印收藏纠错

第一作者： Sangrak,Bae

第一单位： Department of Urology, Uijeongbu St Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

作者： Sangrak,Bae ^[1] ; Ji Hyun,Park ^[2] ; Seyoung,Oh ^[3] ; Gyongseon,Yang ^[3] ; Wei Vivian,Wang ^[4] ; Andrew,Pavelyev ^[5] ; Isaya,Sukarom ^[6]

作者单位： Department of Urology, Uijeongbu St Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. ^[1] Market Access, MSD Korea, Seoul, South Korea. ^[2] Global Medical and Scientific Affairs, MSD Korea, Seoul, South Korea. ^[3] Outcomes Research, Merck & Co., Inc., Rahway, NJ, USA. ^[4] Health Econonomics and Decision Sciences, Merck & Co., Inc., Rahway, NJ, USA. ^[5] Outcomes Research, Regional Asia Pacific, MSD Thailand, Bangkok, Thailand. ^[6]

关键词 9vHPV Cancer gender-neutral vaccination human papillomavirus papillomavirus vaccines